Carregant...

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors.

Protease inhibitors are potent antiviral agents against human immunodeficiency virus type 1. As with reverse transcriptase inhibitors, however, resistance to protease inhibitors can develop and is attributed to the appearance of mutations in the protease gene. With the substrate analog protease inhi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Doyon, L, Croteau, G, Thibeault, D, Poulin, F, Pilote, L, Lamarre, D
Format: Artigo
Idioma:Inglês
Publicat: 1996
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC190252/
https://ncbi.nlm.nih.gov/pubmed/8648711
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!